SCHEDULE 13G: Rubric Capital Management Discloses 5.57% Passive Stake in GoodRx Holdings
Beneficial Ownership Disclosure
Rubric Capital Management LP and David Rosen have disclosed a passive beneficial ownership of 5.57% in GoodRx Holdings, Inc.'s Class A Common Stock.
Summary
- Rubric Capital Management LP and David Rosen, collectively referred to as the 'Reporting Persons,' have filed a Schedule 13G indicating beneficial ownership in GoodRx Holdings, Inc.
- The filing pertains to 5,804,628 shares of GoodRx Holdings, Inc.'s Class A Common Stock, representing 5.57% of the class.
- Rubric Capital Management LP serves as the investment adviser to investment funds and accounts (Rubric Funds) holding these shares, while David Rosen is the Managing Member of Rubric Capital Management GP LLC, the general partner of Rubric Capital.
- The shares are held with shared voting power and shared dispositive power by the Reporting Persons.
- The percentage of ownership is based on 104,272,876 shares of Class A Common Stock outstanding as of October 29, 2024, as reported in GoodRx's Quarterly Report on Form 10-Q filed on November 7, 2024.
- The Reporting Persons certify that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would indicate a positive or negative sentiment regarding the company's performance or outlook.
Future Outlook
NA
Industry Context
This filing indicates a significant institutional investment in GoodRx Holdings, a company operating in the digital healthcare and prescription discount industry. Such disclosures reflect investor confidence or strategic positioning within the evolving healthcare technology landscape.
Stakeholder Impact
- Shareholders: The disclosure of a significant 5.57% stake by an investment firm may be viewed positively, indicating institutional confidence or interest in the company's stock.
Key Dates
| Date | Description |
|---|---|
| October 29, 2024 | Date as of which 104,272,876 shares of Class A Common Stock were outstanding, as reported in the Issuer's Quarterly Report on Form 10-Q. |
| November 7, 2024 | Date the Issuer's Quarterly Report on Form 10-Q for the period ended September 30, 2024, was filed with the SEC. |
| December 31, 2024 | Date of event which requires the filing of this Schedule 13G statement. |
| February 13, 2025 | Date of filing of this Schedule 13G statement by Rubric Capital Management LP and David Rosen. |
Keywords
GoodRx Holdings, Rubric Capital Management, David Rosen, Class A Common Stock, Beneficial Ownership, SEC Filing, Schedule 13G, Investment Adviser, Healthcare Technology, Pharmaceutical Discounts
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.